Product Information

FYREMADEL 250 MCG/0.5 ML SYR is a generic product labeled by Ferring Pharmaceuticals Inc., priced at $56.0440 per ML under NDC 55566101001. Its NADAC has been published 117 times since Aug 21, 2024.

FDA first approved this application on Nov 30, 2018. Its Orange Book therapeutic-equivalence code is AP.

FYREMADEL 250 MCG/0.5 ML SYR

ganirelix acetate
$56.0440per ML

Strength

250 ug/.5mL

NDC

55566101001

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

10/21/2026

Active Ingredients

GANIRELIX ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204246

FDA Approved

11/30/2018

TE Code

AP

On Market Since

2/28/2022

Pharmacological Classes

Decreased GnRH Secretion
Gonadotropin Releasing Hormone Receptor Antagonist
Gonadotropin Releasing Hormone Receptor Antagonists

Price Statistics

The NADAC for FYREMADEL 250 MCG/0.5 ML SYR has been published 117 times since Aug 21, 2024, and over the history we have for it it has declined 44.2%. The table below summarizes its recorded NADAC range and movement.

Current price$56.0440 per ML
All-time high$100.4200 (Sep 11, 2024)
All-time low$56.0440 (Oct 21, 2026)
52-week high$65.1608
52-week low$56.0440
Median price$72.9180
Average price$76.4195
Largest weekly change-10.2% (Aug 20, 2025)
Weeks tracked117
Tracking sinceAug 21, 2024

Price History

1W

0.0%

1M

-10.1%

3M

-10.1%

6M

-10.1%

1Y

-15.2%

3Y

N/A

5Y

N/A

All

-44.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ganirelix acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FYREMADEL 250 MCG/0.5 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FYREMADEL 250 MCG/0.5 ML SYR, manufactured by Ferring Pharmaceuticals Inc., is $56.0440 per ML (NDC 55566101001), effective Nov 11, 2026.

How has the price of FYREMADEL 250 MCG/0.5 ML SYR changed over time?

Over the history we have for it, the NADAC for FYREMADEL 250 MCG/0.5 ML SYR has declined 44.2%. It has been tracked across 117 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for FYREMADEL 250 MCG/0.5 ML SYR?

Since Aug 21, 2024, the NADAC for FYREMADEL 250 MCG/0.5 ML SYR has ranged from a low of $56.0440 (Oct 21, 2026) to a high of $100.4200 (Sep 11, 2024), with a median of $72.9180 per ML.

Are there cheaper alternatives to FYREMADEL 250 MCG/0.5 ML SYR?

No other NADAC-published product currently shares the active ingredient and strength of FYREMADEL 250 MCG/0.5 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FYREMADEL 250 MCG/0.5 ML SYR?

FYREMADEL 250 MCG/0.5 ML SYR (NDC 55566101001) is labeled by Ferring Pharmaceuticals Inc., and CMS classifies it as a generic product.